These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16103080)

  • 1. Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells.
    Shalom-Feuerstein R; Cooks T; Raz A; Kloog Y
    Cancer Res; 2005 Aug; 65(16):7292-300. PubMed ID: 16103080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
    Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
    Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation.
    Paz A; Haklai R; Elad-Sfadia G; Ballan E; Kloog Y
    Oncogene; 2001 Nov; 20(51):7486-93. PubMed ID: 11709720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer.
    Fukumori T; Oka N; Takenaka Y; Nangia-Makker P; Elsamman E; Kasai T; Shono M; Kanayama HO; Ellerhorst J; Lotan R; Raz A
    Cancer Res; 2006 Mar; 66(6):3114-9. PubMed ID: 16540661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the nuclear import pathways of galectin-3.
    Nakahara S; Oka N; Wang Y; Hogan V; Inohara H; Raz A
    Cancer Res; 2006 Oct; 66(20):9995-10006. PubMed ID: 17047062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras activation in response to phorbol ester proceeds independently of the EGFR via an unconventional nucleotide-exchange factor system in COS-7 cells.
    Rubio I; Rennert K; Wittig U; Beer K; Dürst M; Stang SL; Stone J; Wetzker R
    Biochem J; 2006 Sep; 398(2):243-56. PubMed ID: 16709153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.
    Pervin S; Singh R; Hernandez E; Wu G; Chaudhuri G
    Cancer Res; 2007 Jan; 67(1):289-99. PubMed ID: 17210710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase.
    Scuto A; Zhang H; Zhao H; Rivera M; Yeatman TJ; Jove R; Torres-Roca JF
    Cancer Res; 2007 Nov; 67(21):10317-24. PubMed ID: 17974974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained activation of M-Ras induced by nerve growth factor is essential for neuronal differentiation of PC12 cells.
    Sun P; Watanabe H; Takano K; Yokoyama T; Fujisawa J; Endo T
    Genes Cells; 2006 Sep; 11(9):1097-113. PubMed ID: 16923128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
    Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
    Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38.
    Dreissigacker U; Mueller MS; Unger M; Siegert P; Genze F; Gierschik P; Giehl K
    Cell Signal; 2006 Aug; 18(8):1156-68. PubMed ID: 16257181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
    Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A
    Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional characterization of a novel interleukin 17 receptor: a possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway.
    Li TS; Li XN; Chang ZJ; Fu XY; Liu L
    Cell Signal; 2006 Aug; 18(8):1287-98. PubMed ID: 16310341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
    Kogut MH; Genovese KJ; He H
    Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
    Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
    Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras nanoclustering is subverted by overexpression of the scaffold protein galectin-3.
    Shalom-Feuerstein R; Plowman SJ; Rotblat B; Ariotti N; Tian T; Hancock JF; Kloog Y
    Cancer Res; 2008 Aug; 68(16):6608-16. PubMed ID: 18701484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
    Fan S; Meng Q; Laterra JJ; Rosen EM
    Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity.
    Elad-Sfadia G; Haklai R; Balan E; Kloog Y
    J Biol Chem; 2004 Aug; 279(33):34922-30. PubMed ID: 15205467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.